22.25 USD
▲+0.26+3.92%
盘后 21.68 +1.27%
2026-08-03
市值
$1.21B
市盈率
—
EPS
-46.32
股息率
—
52 周区间
6.50 – 50.20
成交量
834.87K
Beta
1.70
目标价
37.88
52W 低 6.5052W 高 50.20
价格走势
公司简介
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and...